{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:38:29Z","timestamp":1782135509849,"version":"3.54.5"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T00:00:00Z","timestamp":1522022400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009342","name":"Aeras Global Tuberculosis Vaccine Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00564","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T09:54:55Z","timestamp":1522058095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72\/AS01 in Bacillus Calmette\u2013Gu\u00e9rin-Vaccinated Adults"],"prefix":"10.3389","volume":"9","author":[{"given":"Robert A.","family":"van den Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurane","family":"De Mot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Leroux-Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Bechtold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Jongert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert G.","family":"van der Most","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,26]]},"reference":[{"key":"B1","volume-title":"Global Tuberculosis Report 2013","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nrmicro2236-c1","article-title":"Spectrum of latent tuberculosis \u2013 existing tests cannot resolve the underlying phenotypes","volume":"8","author":"Pai","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tim.2009.02.005","article-title":"Eliminating latent tuberculosis","volume":"17","author":"Young","year":"2009","journal-title":"Trends Microbiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.molmed.2007.03.004","article-title":"The prognosis of latent tuberculosis: can disease be predicted?","volume":"13","author":"Andersen","year":"2007","journal-title":"Trends Mol Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1164\/rccm.201208-1385OC","article-title":"Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72\/AS01 in South African adults","volume":"188","author":"Day","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tube.2016.07.005","article-title":"Safety and immunogenicity of the M72\/AS01E candidate tuberculosis vaccine in adults with tuberculosis: a phase II randomised study","volume":"100","author":"Gillard","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","article-title":"Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial","volume":"31","author":"Leroux-Roels","year":"2013","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s10875-013-9949-3","article-title":"A randomized, controlled dose-finding Phase II study of the M72\/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults","volume":"33","author":"Montoya","year":"2013","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1016\/j.vaccine.2015.05.088","article-title":"Safety and immunogenicity of candidate vaccine M72\/AS01E in adolescents in a TB endemic setting","volume":"33","author":"Penn-Nicholson","year":"2015","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e2459","DOI":"10.1097\/MD.0000000000002459","article-title":"A randomized, controlled safety, and immunogenicity trial of the M72\/AS01 candidate tuberculosis vaccine in HIV-positive Indian adults","volume":"95","author":"Kumarasamy","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.tube.2014.07.001","article-title":"Safety and immunogenicity of the M72\/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial","volume":"94","author":"Idoko","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1097\/QAD.0000000000000343","article-title":"Safety and immunogenicity of the M72\/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I\/II, randomized trial","volume":"28","author":"Thacher","year":"2014","journal-title":"AIDS"},{"key":"B16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-1-4614-6111-1_7","article-title":"Cytokines in the balance of protection and pathology during mycobacterial infections","volume":"783","author":"Torrado","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB","volume":"12","author":"Nunes-Alves","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns","volume":"182","author":"Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"Mittr\u00fccker","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1128\/IAI.74.4.2128-2137.2006","article-title":"An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis","volume":"74","author":"Majlessi","year":"2006","journal-title":"Infect Immun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1016\/j.vaccine.2011.02.010","article-title":"Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells","volume":"29","author":"Derrick","year":"2011","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11290","DOI":"10.1038\/ncomms11290","article-title":"T-cell activation is an immune correlate of risk in BCG vaccinated infants","volume":"7","author":"Fletcher","year":"2016","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S1473-3099(13)70034-3","article-title":"Tuberculosis biomarkers discovery: developments, needs, and challenges","volume":"13","author":"Wallis","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.coi.2013.08.003","article-title":"Systems approaches to studying the immune response in tuberculosis","volume":"25","author":"Berry","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1016\/j.vaccine.2015.07.090","article-title":"Profiling the host immune response to tuberculosis vaccines","volume":"33","author":"Fletcher","year":"2015","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e70630","DOI":"10.1371\/journal.pone.0070630","article-title":"Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers","volume":"8","author":"Bloom","year":"2013","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/gene.2010.51","article-title":"Human gene expression profiles of susceptibility and resistance in tuberculosis","volume":"12","author":"Maertzdorf","year":"2011","journal-title":"Genes Immun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e46191","DOI":"10.1371\/journal.pone.0046191","article-title":"Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy","volume":"7","author":"Bloom","year":"2012","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1093\/infdis\/jis546","article-title":"High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination","volume":"206","author":"Haralambieva","year":"2012","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e62149","DOI":"10.1371\/journal.pone.0062149","article-title":"Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination","volume":"8","author":"Haralambieva","year":"2013","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1038\/srep02327","article-title":"High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature","volume":"3","author":"Henn","year":"2013","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.immuni.2012.12.008","article-title":"Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines","volume":"38","author":"Obermoser","year":"2013","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/ni.2067","article-title":"Systems biology of vaccination for seasonal influenza in humans","volume":"12","author":"Nakaya","year":"2011","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"E3503","DOI":"10.1073\/pnas.1208972109","article-title":"Merck Ad5\/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity","volume":"109","author":"Zak","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1073\/pnas.1621489114","article-title":"Systems analysis of protective immune responses to RTS,S malaria vaccination in humans","volume":"114","author":"Kazmin","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fimmu.2017.00557","article-title":"Predicting RTS,S vaccine-mediated protection from transcriptomes in a malaria-challenge clinical trial","volume":"8","author":"van den Berg","year":"2017","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1586\/erv.11.29","article-title":"Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems","volume":"10","author":"Gar\u00e7on","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"B43","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1086\/650310","article-title":"Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine","volume":"201","author":"Vahey","year":"2010","journal-title":"J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2014.09.001","article-title":"Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naive HIV-1-infected patients","volume":"414","author":"Bourguignon","year":"2014","journal-title":"J Immunol Methods"},{"key":"B45","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.4049\/jimmunol.161.10.5284","article-title":"Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis","volume":"161","author":"Waldrop","year":"1998","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1198\/016214504000000683","article-title":"A model-based background adjustment for oligonucleotide expression arrays","volume":"99","author":"Wu","year":"2004","journal-title":"J Am Stat Assoc"},{"key":"B47","volume-title":"Low Level Analysis of High-density Oligonucleotide Array Data: Background, Normalization and Summarization","author":"Bolstad","year":"2004"},{"key":"B48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/0-387-29362-0_3","article-title":"Quality assessment of affymetrix GeneChip data","volume-title":"Bioinformatics and Computational Biology Solutions Using R and Bioconductor","author":"Bolstad","year":"2005"},{"key":"B49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1198\/004017008000000334","article-title":"Quality assessment for short oligonucleotide microarray data technometrics","volume":"50","author":"Brettschneider","year":"2008","journal-title":"Technometrics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1214\/16-AOAS920","article-title":"Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression","volume":"10","author":"Phipson","year":"2016","journal-title":"Ann Appl Stat"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B52","first-page":"60","article-title":"Statistics for differential expression","volume-title":"limma: Linear Models for Microarray and RNA-seq Data User\u2019s Guide","author":"Smyth","year":"2016"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e2420v1","DOI":"10.7287\/peerj.preprints.2420v1","article-title":"tmod: an R package for general and multivariate enrichment analysis","volume":"4","author":"Weiner","year":"2016","journal-title":"PeerJ Preprints"},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.1201\/9780429246593","volume-title":"An Introduction to the Bootstrap","author":"Efron","year":"1994"},{"key":"B55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"Kester","year":"2009","journal-title":"J Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.smim.2013.05.003","article-title":"Systems biological approaches to measure and understand vaccine immunity in humans","volume":"25","author":"Li","year":"2013","journal-title":"Semin Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.4049\/jimmunol.1400948","article-title":"Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells","volume":"193","author":"Didierlaurent","year":"2014","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41541-017-0027-3","article-title":"Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFN\u03b3 response promoting vaccine immunogenicity","volume":"2","author":"Coccia","year":"2017","journal-title":"NPJ Vaccines"},{"key":"B59","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1101\/sqb.2013.78.022905","article-title":"The promised land of human immunology","volume":"78","author":"Su","year":"2013","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/21645515.2017.1381809","article-title":"Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine","volume":"14","author":"Moris","year":"2017","journal-title":"Hum Vaccin Immunother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00564\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T09:33:42Z","timestamp":1719912822000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00564\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,26]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2018.00564"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00564","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,26]]},"article-number":"564"}}